Cognitive Deficits in Methamphetamine Users: How Strong is The Evidence?

Abstract Methamphetamine use has spread in many European countries and the United States. The current review provides a summary and critical analysis of research on cognitive deficits associated with methamphetamine, also known as “crystal meth.” The literature search performed for this review led us to the hypothesis that methamphetamine use is associated with persistent changes in brain metabolism that result in various impairments, such as deficits in memory, attention, and concentration. The dopaminergic system in particular seems to be affected. Some studies indicate that cognitive impairments may improve when users become abstinent, but results of other studies are conflicting. This review discusses these findings and the consequences for the development of a specific addiction treatment for methamphetamine.

[1]  U. Bonnet,et al.  Dramatic Changes Over Time of Methamphetamine Intake in a German, HIV-Positive, Sample of Men who have Sex with Men (MSM) , 2017, Pharmacopsychiatry.

[2]  M. Rüdiger,et al.  Methamphetamine Consumption during Pregnancy – Effects on Child Health , 2017, Pharmacopsychiatry.

[3]  L. Kraus,et al.  Substanzkonsum in der Allgemeinbevölkerung in Deutschland. Ergebnisse des Epidemiologischen Suchtsurveys 2015 , 2016 .

[4]  R. See,et al.  Chronic methamphetamine self-administration disrupts cortical control of cognition , 2016, Neuroscience & Biobehavioral Reviews.

[5]  Min Zhao,et al.  The cognitive impairments and psychological wellbeing of methamphetamine dependent patients compared with health controls , 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[6]  J. Loftis,et al.  Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study , 2015, Front. Psychiatry.

[7]  Milky Kohno,et al.  Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging , 2015, Brain Research.

[8]  David N. Linsenbardt,et al.  Methamphetamine-induced deficits in social interaction are not observed following abstinence from single or repeated exposures , 2015, Behavioural pharmacology.

[9]  R. Härtel-Petri Crystal-Meth als Herausforderung für das Suchthilfesystem – Klinische Empfehlungen , 2015, Suchttherapie.

[10]  Liang-Jen Wang,et al.  Predictors of Relapse and Dropout During a 12-Week Relapse Prevention Program for Methamphetamine Users , 2015, Journal of psychoactive drugs.

[11]  J. Raduà,et al.  Gray matter abnormalities in cocaine versus methamphetamine-dependent patients: a neuroimaging meta-analysis , 2015, The American journal of drug and alcohol abuse.

[12]  P. Renshaw,et al.  Predisposition to and effects of methamphetamine use on the adolescent brain , 2015, Molecular Psychiatry.

[13]  I. Grant,et al.  Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and Mice , 2015, Neuropsychopharmacology.

[14]  Dan J Stein,et al.  Methamphetamine and cannabis abuse in adolescence: a quasi-experimental study on specific and long-term neurocognitive effects , 2015, BMJ Open.

[15]  Colm G. Connolly,et al.  A voxel-based morphometry study of young occasional users of amphetamine-type stimulants and cocaine. , 2014, Drug and alcohol dependence.

[16]  L. Kraus,et al.  Substanzkonsum und substanzbezogene Störungen in Deutschland im Jahr 2012 , 2013 .

[17]  April C. May,et al.  Methamphetamine dependent individuals show attenuated brain response to pleasant interoceptive stimuli. , 2013, Drug and alcohol dependence.

[18]  John T. Clark,et al.  Chronic methamphetamine exposure produces a delayed, long‐lasting memory deficit , 2013, Synapse.

[19]  W. Honer,et al.  Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. , 2013, Drug and alcohol dependence.

[20]  A. Waters,et al.  Cognitive enhancement as a treatment for drug addictions , 2013, Neuropharmacology.

[21]  S. O'dell,et al.  Methamphetamine influences on brain and behavior: unsafe at any speed? , 2012, Trends in Neurosciences.

[22]  M. Preiss,et al.  Comparison of Wisconsin Card Sorting Test results between Czech subjects dependent on methamphetamine versus healthy volunteers. , 2012, Psychiatria Danubina.

[23]  Edward E. Smith,et al.  Is Cognitive Functioning Impaired in Methamphetamine Users? A Critical Review , 2012, Neuropsychopharmacology.

[24]  Linda Chang,et al.  Age and sex effects levels of choline compounds in the anterior cingulate cortex of adolescent methamphetamine users. , 2011, Drug and alcohol dependence.

[25]  D. Rusyniak Neurologic manifestations of chronic methamphetamine abuse. , 2011, Neurologic clinics.

[26]  A. Fellgiebel,et al.  Non-Medical Use of Prescription Stimulants and Illicit Use of Stimulants for Cognitive Enhancement in Pupils and Students in Germany , 2010, Pharmacopsychiatry.

[27]  N. Volkow,et al.  Distribution and Pharmacokinetics of Methamphetamine in the Human Body: Clinical Implications , 2010, PloS one.

[28]  F. Vaida,et al.  Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults. , 2010, Drug and alcohol dependence.

[29]  Catherine A. Sugar,et al.  Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables. , 2009, Drug and alcohol dependence.

[30]  T. Nordahl,et al.  Drug abstinence and cognitive control in methamphetamine-dependent individuals. , 2009, Journal of substance abuse treatment.

[31]  Hans Förstl Neuro-Enhancement , 2009, Der Nervenarzt.

[32]  Chris Cruickshank,et al.  A review of the clinical pharmacology of methamphetamine. , 2009, Addiction.

[33]  Marc N. Potenza,et al.  Pretreatment Brain Activation During Stroop Task Is Associated with Outcomes in Cocaine-Dependent Patients , 2008, Biological Psychiatry.

[34]  Alan A. Wilson,et al.  Increased Vesicular Monoamine Transporter Binding during Early Abstinence In Human Methamphetamine Users: Is VMAT2 a Stable Dopamine Neuron Biomarker? , 2008, The Journal of Neuroscience.

[35]  B. Homer,et al.  Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications. , 2008, Psychological bulletin.

[36]  Deborah A Yurgelun-Todd,et al.  Performance on the Stroop Predicts Treatment Compliance in Cocaine-Dependent Individuals , 2008, Neuropsychopharmacology.

[37]  J. Cadet,et al.  Interactions of HIV and methamphetamine: Cellular and molecular mechanisms of toxicity potentiation , 2007, Neurotoxicity Research.

[38]  I. Grant,et al.  Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis , 2007, Neuropsychology Review.

[39]  M. Buonocore,et al.  Attentional Control and Brain Metabolite Levels in Methamphetamine Abusers , 2007, Biological Psychiatry.

[40]  N. Volkow,et al.  Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. , 2007, Addiction.

[41]  Young T. Hong,et al.  Nucleus Accumbens D2/3 Receptors Predict Trait Impulsivity and Cocaine Reinforcement , 2007, Science.

[42]  W. Honer,et al.  The need for speed: an update on methamphetamine addiction. , 2006, Journal of psychiatry & neuroscience : JPN.

[43]  R. Croft,et al.  The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance , 2006, Psychopharmacology.

[44]  Antoine Bechara,et al.  Executive dysfunction in substance dependent individuals during drug use and abstinence: An examination of the behavioral, cognitive and emotional correlates of addiction , 2006, Journal of the International Neuropsychological Society.

[45]  Luke Clark,et al.  Profile of Executive and Memory Function Associated with Amphetamine and Opiate Dependence , 2006, Neuropsychopharmacology.

[46]  K. Bush,et al.  A Comparison of Methamphetamine-Dependent Inpatients With and Without Childhood Attention Deficit Hyperactivity Disorder Symptomatology , 2005 .

[47]  A. Saxon,et al.  Implications of chronic methamphetamine use: a literature review. , 2005, Harvard review of psychiatry.

[48]  Julie C. Stout,et al.  Neurocognitive insights into substance abuse , 2005, Trends in Cognitive Sciences.

[49]  D. Sulzer,et al.  Mechanisms of neurotransmitter release by amphetamines: A review , 2005, Progress in Neurobiology.

[50]  C. Wallace,et al.  Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition , 2005, Psychopharmacology.

[51]  I. Grant,et al.  Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. , 2004, Drug and alcohol dependence.

[52]  K. Kendler,et al.  A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs , 2004, Psychological Medicine.

[53]  W. Ling,et al.  The effect of relapse on cognition in abstinent methamphetamine abusers. , 2004, Journal of substance abuse treatment.

[54]  Paul M. Thompson,et al.  Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine , 2004, The Journal of Neuroscience.

[55]  Walter Ling,et al.  Methamphetamine abstinence syndrome: preliminary findings. , 2004, The American journal on addictions.

[56]  N. Volkow,et al.  Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. , 2004, The American journal of psychiatry.

[57]  I. Grant,et al.  Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons , 2004, Journal of the International Neuropsychological Society.

[58]  J. Hornung,et al.  The human raphe nuclei and the serotonergic system , 2003, Journal of Chemical Neuroanatomy.

[59]  M. Iyo,et al.  Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. , 2003, The American journal of psychiatry.

[60]  Edward Nunes,et al.  Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. , 2003, Drug and alcohol dependence.

[61]  T. Nordahl,et al.  Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. , 2003, The Journal of neuropsychiatry and clinical neurosciences.

[62]  Michael F. Green,et al.  Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. , 2003, The Journal of neuropsychiatry and clinical neurosciences.

[63]  J. O'Callaghan,et al.  Elevated environmental temperature and methamphetamine neurotoxicity. , 2003, Environmental research.

[64]  J. Hall,et al.  Treatment of methamphetamine abuse: research findings and clinical directions. , 2003, Journal of substance abuse treatment.

[65]  R. Engle,et al.  Working-memory capacity and the control of attention: the contributions of goal neglect, response competition, and task set to Stroop interference. , 2003, Journal of experimental psychology. General.

[66]  S. Nixon,et al.  Cognitive efficiency in stimulant abusers with and without alcohol dependence. , 2003, Alcoholism, clinical and experimental research.

[67]  A. Pfefferbaum,et al.  Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals , 2002, Psychiatry Research.

[68]  Linda Chang,et al.  Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users , 2002, Psychiatry Research: Neuroimaging.

[69]  B. Logan,et al.  Methamphetamine - Effects on Human Performance and Behavior. , 2002, Forensic science review.

[70]  A. Cho,et al.  Patterns of Methamphetamine Abuse and Their Consequences , 2001, Journal of addictive diseases.

[71]  C. Hart,et al.  Methamphetamine self-administration by humans , 2001, Psychopharmacology.

[72]  J S Fowler,et al.  Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. , 2001, The American journal of psychiatry.

[73]  G. Bray Use and Abuse of Appetite-Suppressant Drugs in the Treatment of Obesity , 1993, Annals of Internal Medicine.

[74]  R. E. Hicks,et al.  Clinical effects of daily methamphetamine administration. , 1991, Clinical neuropharmacology.

[75]  W. Roth,et al.  Sensitivity of some human cognitive functions to effects of methamphetamine and secobarbital. , 1980, Drug and alcohol dependence.

[76]  W. Roth,et al.  Methamphetamine and diphenhydramine effects on the rate of cognitive processing , 1978, Psychopharmacology.

[77]  M. Soyka,et al.  Prävalenz und Therapie bei Abhängigkeit von Methamphetamin („Crystal“) , 2017 .

[78]  M. Soyka,et al.  [Prevalence and Therapy of Crystal Methamphetamine Dependence]. , 2017, Fortschritte der Neurologie-Psychiatrie.

[79]  H. Ekhtiari,et al.  Perspectives on neurocognitive rehabilitation as an adjunct treatment for addictive disorders: From cognitive improvement to relapse prevention. , 2016, Progress in brain research.

[80]  I. Grant,et al.  Depression and executive dysfunction contribute to a metamemory deficit among individuals with methamphetamine use disorders. , 2015, Addictive behaviors.

[81]  R. See,et al.  Modafinil restores methamphetamine induced object-in-place memory deficits in rats independent of glutamate N-methyl-D-aspartate receptor expression. , 2014, Drug and alcohol dependence.

[82]  Emcdda Papers Exploring methamphetamine trends in Europe EMCDDA PAPERS , 2014 .

[83]  Renate Drechsler,et al.  Exekutive Funktionen: Übersicht und Taxonomie , 2007 .

[84]  K. Bush,et al.  A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatology. , 2005, Journal of addictive diseases.

[85]  M. Brecht,et al.  Methamphetamine use behaviors and gender differences. , 2004, Addictive behaviors.

[86]  Marc A Schuckit,et al.  Behavioral and Functional Neuroimaging Evidence for Prefrontal Dysfunction in Methamphetamine-Dependent Subjects , 2002, Neuropsychopharmacology.

[87]  H. Hentschel Ecstasy und Co. — Sind Partydrogen wirklich harmlos? , 2001 .

[88]  T. Robbins,et al.  Neuroscience and Biobehavioral Reviews Review from the Ventral to the Dorsal Striatum: Devolving Views of Their Roles in Drug Addiction , 2022 .